GSK, Pfizer To Merge Consumer Healthcare Units
Mohammad Ali (@ChaudhryMAli88) Published December 19, 2018 | 04:49 PM
Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.
London, (UrduPoint / Pakistan Point News - 19th Dec, 2018 ) :Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.
GSK said it would have a 68-percent controlling equity interest in the joint venture that will have combined sales of about �9.8 billion ($12.7 billion, 10.9 billion Euros).
The deal paves the way for British group GSK to have two UK-listed companies, one specialised in the development of drugs and the other in consumer healthcare.
It comes as the pharmaceutical industry's biggest players seek out new blockbuster treatments following expiry of patents for some of their major drugs that has enabled smaller rivals to offer cheaper alternatives.
"Within three years of the closing of the transaction, GSK intends to separate the joint venture via a demerger of its equity interest and a listing of GSK Consumer Healthcare on the UK equity market," a statement said.
"Over this period, GSK will substantially complete the integration and expects to make continued progress in strengthening its Pharmaceuticals business and R&D pipeline." In a separate statement, US giant Pfizer said the joint venture "will be a category leader in pain relief, respiratory, vitamin and mineral supplements, digestive health, skin health and therapeutic oral health and will be the largest global consumer healthcare business".
GSK chief executive Emma Walmsley said "the transaction also presents a clear pathway forward for GSK to create a new global Pharmaceuticals/Vaccines company... focused on science related to the immune system, use of genetics and advanced technologies".
She added: "Ultimately, our goal is to create two exceptional, UK-based global companies, with appropriate capital structures, that are each well positioned to deliver improving returns to shareholders and significant benefits to patients and consumers."
Related Topics
Recent Stories
Zhao Shirin calls on Punjab Industries Minister
Immunization campaign to protect children from deadly diseases in full swing
Action taken against officers not recovering 85% tax: Secretary
Haiti transitional council sworn in after months of violence
IHC adjourns cipher case hearing against PTI founder till April 20,
Ukrainian village battles mines year after Russia forced out
Collective efforts needed to curb terrorism: Barrister Saif
China's Shenzhou-18 mission takes off bound for space station
Police arrest 4 suspects, recovered phones, bikes
Thousands of flights scrapped as French air traffic controllers strike
WWB directed to identify board’s land for revenue generation
Poverty to be ended by establishing border markets: Balochistan Governor
More Stories From Business
-
Zhao Shirin calls on Punjab Industries Minister
11 minutes ago -
CEO APM Terminals calls on Finance Minister
15 minutes ago -
SACM visits GTVC checks attendance register
21 minutes ago -
CEO APM Terminals meets Commerce Minister
21 minutes ago -
RTO destroys huge quantity of non-duty paid cigarettes
58 minutes ago -
Pakistan's total liquid foreign reserves reach $ 13.28 billion
47 minutes ago
-
RDA inflows rise to $7.660 bn in March 24
47 minutes ago -
FPCCI welcomes direct flights between Pakistan-Azerbaijan
38 minutes ago -
Faysal Bank unveils strong financial results for the Q1’24
38 minutes ago -
US economic growth slows to 1.6% in first quarter
12 minutes ago -
Collaborative Care of Diabetes Centre inaugurated in Faisalabad
3 hours ago -
Kazakh envoy stresses quantum jump in bilateral trade
2 hours ago